Knowing what to ask your doctor about your CLL treatment can help you feel more comfortable with your diagnosis and know what to expect for the future. There are many treatment options ...

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

In chronic lymphocytic leukemia (CLL), the most prevalent lymphoid malignancy in western countries, patients have a median age at diagnosis of 72 years. In the last few years, there has been ...

Tumor lysis syndrome: rapid tumor breakdown causing harmful ... Chemoimmunotherapy: treatment combining chemotherapy and immunotherapy. Brown is the director of the CLL Center of the Division of ...

"Patients with treatment-naive CLL have several treatment options ... pointed to the fact that there were no cases of substantial clinical tumor lysis syndrome (TLS) in AMPLIFY; the risk of ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

Here we focus on the transformation assay, which scientists first used to identify oncogenes and tumor suppressors and study their affect on cell cycle progression. Even more important will be ...

Ablative therapy means we're not removing the tumor; we're killing the tumor with either radiation or microwave energy or radiofrequency energy, or now, ultrasound energy. The concept was ...

ICP-248 exerts anti-tumor activity by selectively inhibiting ... will provide deeper remission for treatment-naïve CLL/SLL patients without drug-resistant mutations, bringing hope of clinical ...